Literature DB >> 2675316

Paroxysmal nocturnal hemoglobinuria.

B Rotoli1, L Luzzatto.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2675316

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  25 in total

1.  Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.

Authors:  T H Bugge; M J Flick; M J Danton; C C Daugherty; J Romer; K Dano; P Carmeliet; D Collen; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias.

Authors:  John Meletis; Evangelos Terpos; Michalis Samarkos; Christos Meletis; Effie Apostolidou; Veroniki Komninaka; Konstantinos Korovesis; Konstantinos Anargyrou; Olga Benopoulou; Despina Mavrogianni; Eleni Variami; Nora Viniou; Konstantinos Konstantopoulos
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

Review 3.  Molecular genetics of paroxysmal nocturnal hemoglobinuria.

Authors:  Norimitsu Inoue; Yoshiko Murakami; Taroh Kinoshita
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

4.  A 43-year-old woman with severe pancytopenia and a splenic hematoma.

Authors:  E V Planken; G J den Ottolander; P M Kluin; R Bieger
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673

5.  Clonality in context: hematopoietic clones in their marrow environment.

Authors:  James N Cooper; Neal S Young
Journal:  Blood       Date:  2017-10-18       Impact factor: 22.113

6.  Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

Authors:  Lova Sun; Daria V Babushok
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 7.  Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria.

Authors:  Lucio Luzzatto; Giacomo Gianfaldoni
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

8.  Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.

Authors:  H Nakakuma; M Hidaka; S Nagakura; Y Nishimura; N Iwamoto; K Horikawa; T Kawaguchi; T Kagimoto; K Takatsuki
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Glycosylphosphatidylinositol (GPI)-anchored surface antigens in the allogeneic activation of T cells.

Authors:  J Schubert; A Stroehmann; C Scholz; R E Schmidt
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  P Hillmen; M Bessler; P J Mason; W M Watkins; L Luzzatto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.